Document is current
Any future updates will be listed below
-
Authors
Mattsson‐Carlgren, Niklas https://orcid.org/0000-0002-8885-7724
Janelidze, Shorena
Bateman, Randall J
Smith, Ruben
Stomrud, Erik
Serrano, Geidy E
Reiman, Eric M
Palmqvist, Sebastian https://orcid.org/0000-0002-9267-1930
Dage, Jeffrey L
Beach, Thomas G
Hansson, Oskar https://orcid.org/0000-0001-8467-7286
-
Funding
Funding for this research was provided by:
The Swedish Research council (2016‐00906)
Kunt and Alice Wallenberg Foundation (2017‐0383)
Medical Faculty, Lund University and Region Skåne (NMC 2019‐2022)
The Marianne and Marcus Wallenberg Foundation (2015.0125)
The Strategic Research Area MultiPark, Lund University
The Swedish Alzheimer Foundation (AF‐939932)
The Swedish Brain Foundation (FO2019‐0326)
The Swedish Brain Foundation (FO2020‐0275)
The Parkinson foundation of Sweden (1280/20)
The Skåne University Hospital Foundation (2020‐O000028)
Regionalt Forskningsstöd (2020‐0314)
The Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse (2020 NMC)
The Bundy Academy (Stora Priset 2020 NMC)
Swedish Federal Government under the ALF agreement (2018‐Projekt0279)
Swedish Federal Government under the ALF agreement (2018‐Projekt0054)
National Institute of Neurological Disorders and Stroke (U24 NS072026)
National Institute on Aging (P30 AG19610)
The Arizona Department of Health Services
The Arizona Biomedical Research Commission (4001 0011 05‐901 1001)
The Arizona Department of Health Services
The Michael J. Fox Foundation for Parkinson's Research
- License Information
-
More Information
Article History
Received: 26 January 2021
Revised: 18 March 2021
Accepted: 23 March 2021
First Online: 5 May 2021
Conflict of interest
: OH has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Alzpath, Biogen, Cerveau, and Roche. NMC, ES, SP, SJ, and RS have no disclosures. TGB has had research support from the National Institute on Aging, Michael J Fox Foundation for Parkinson’s Research, and the State of Arizona and, in the past 2 years, has received consultancy and/or speaker fees from Prothena Biosciences and Vivid Genomics. JLD is an employee of Eli Lilly and Company. Remaining co‐authors report no disclosures.
